Al Hammadi Holding Co.’s Q1 2025 net profit jumped 15% to SAR 73.9 million, from SAR 64 million in the year-earlier period.
Item | Q1 2024 | Q1 2025 | Change |
---|---|---|---|
Revenues | 277.04 | 301.88 | 9.0 % |
Gross Income | 91.06 | 96.51 | 6.0 % |
Operating Income | 68.17 | 70.77 | 3.8 % |
Net Income | 64.04 | 73.93 | 15.4 % |
Average Shares | 160.00 | 160.00 | - |
Earnings Per Share before unusual items (Riyal) | 0.40 | 0.46 | 15.4 % |
EPS (Riyal) | 0.40 | 0.46 | 15.4 % |
Item | Q4 2024 | Q1 2025 | Change |
---|---|---|---|
Revenues | 322.79 | 301.88 | (6.5 %) |
Gross Income | 109.61 | 96.51 | (12.0 %) |
Operating Income | 71.52 | 70.77 | (1.1 %) |
Net Income | 77.76 | 73.93 | (4.9 %) |
Average Shares | 160.00 | 160.00 | - |
Earnings Per Share before unusual items (Riyal) | 0.49 | 0.46 | (4.9 %) |
EPS (Riyal) | 0.49 | 0.46 | (4.9 %) |
The profit increase was driven by a 9% increase year-on-year (YoY) in revenues to SAR 301.88 million in Q1 2025, primarily due to higher earnings of medical services and pharmaceutical products segments.
The company recorded a finance income of SAR 2.03 million due to an increase in its cash balance and improved collection efficiency.
Meanwhile, there was an increase in the share of profits from an associate company to reach SAR 5.5 million during the current quarter.
The healthcare services provider’s quarterly net profit fell nearly 5% from SAR 77.76 million in Q1 2024.
Shareholders’ equity, no minority interest, increased to SAR 1.98 billion by the end of Q1 2025, from SAR 1.85 billion a year earlier.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: